Lineage, Inc. Common Stock (LINE)vsRithm Capital Corp. (RITM)
LINE
Lineage, Inc. Common Stock
$42.63
-1.32%
REAL ESTATE · Cap: $11.14B
RITM
Rithm Capital Corp.
$9.13
-0.44%
REAL ESTATE · Cap: $5.20B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 26% more annual revenue ($5.36B vs $4.24B). RITM leads profitability with a 17.0% profit margin vs -2.7%. RITM earns a higher WallStSmart Score of 69/100 (B-).
LINE
Avoid34
out of 100
Grade: F
RITM
Strong Buy69
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+83.6%
Fair Value
$65.11
Current Price
$9.13
$55.98 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Revenue surging 64.6% year-over-year
Earnings expanding 72.2% YoY
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
Weak financial health signals
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : RITM
The strongest argument for RITM centers on P/E Ratio, Price/Book, Revenue Growth. Profitability is solid with margins at 17.0% and operating margin at 13.2%. Revenue growth of 64.6% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : RITM
The primary concerns for RITM are Piotroski F-Score, Altman Z-Score, Debt/Equity. Debt-to-equity of 4.62 is elevated, increasing financial risk.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while RITM is a growth play — different risk/reward profiles.
RITM is growing revenue faster at 64.6% — sustainability is the question.
RITM generates stronger free cash flow (254M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RITM scores higher overall (69/100 vs 34/100), backed by strong 17.0% margins and 64.6% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.
Visit Website →Rithm Capital Corp.
REAL ESTATE · REIT - MORTGAGE · USA
Rhythm Capital Corp. The company is headquartered in New York, New York.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?